Feature | May 06, 2014

SCAI 2014 Scientific Sessions to Explore Google Glass Technology’s Role in Interventional Cardiology

May 6, 2014 — Technology’s newest tool and its potential to improve patient care will be the focus of a first-of-its-kind special session at the 2014 Society for Cardiovascular Angiography and Interventions (SCAI) scientific sessions in Las Vegas. In line with interventional cardiology’s long commitment to innovation that results in improved patient outcomes, the in-depth session on Google Glass will explore the concept of wearable technology in medicine, how interventional cardiologists are already using it to transform education, and both the challenges and opportunities for more widespread use in the future.

“We are at an exciting point in our profession, where we are discussing a technology whose potential uses can transform the work we do, from the care we provide patients to the education we share with one another,” said Morton J. Kern, M.D., FSCAI, SCAI 2014 program director and co-moderator of the session. “Interventional cardiology has focused on innovating to save lives and improve care for heart disease patients for nearly 40 years. Examining Google Glass at the SCAI annual meeting is a natural fit and an ideal venue for us to examine how such new technology can be applied to diagnosis and treatment of cardiovascular disease.”

Google Glass is a wearable computer developed by Google with the mission of bringing hands-free technology to the public. Worn as a headset similar to eyeglasses, the Google Glass device displays smartphone-like information and allows users to communicate commands with their voice. Currently unavailable to consumers, Google Glass users are part of its beta-testing program “Glass Explorers.”

In addition to reviewing what Google Glass is and how it works, the SCAI 2014 session will focus on how it will improve medical care, how it is currently being used as a tele-mentoring tool around the world, and the challenges physicians and their teams face as they implement it into practice. Speakers will include physicians from around the country who are exploring technology in their practice.

“Just as smartphones have transformed our everyday lives in ways we once thought unimaginable, it is hard to imagine the effect the next technology phase will have,” said Barry F. Uretsky, M.D., FSCAI, session co-moderator. “This session will help us understand this next phase and imagine the possibilities for patient care that are coming in the not-too-distant future.”

The session, “Applications of Google Glass to Improve Outcomes in Interventional Cardiology,” will be held Wed., May 28.

For more information: www.scai.org

Related Content

Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init